Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.